IRADIMED CORP Files 8-K on Security Holder Vote
Ticker: IRMD · Form: 8-K · Filed: Jun 20, 2024 · CIK: 1325618
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
IRADIMED CORP held a shareholder vote on June 20, 2024. Details TBD.
AI Summary
On June 20, 2024, IRADIMED CORP filed an 8-K report indicating that matters were submitted to a vote of security holders. The filing does not contain details on the specific proposals voted upon or the outcome of the vote.
Why It Matters
This filing signals that important corporate decisions requiring shareholder approval have been put to a vote, which could impact the company's future direction.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose any immediate financial or operational risks.
Key Players & Entities
- IRADIMED CORP (company) — Registrant
- June 20, 2024 (date) — Date of report
FAQ
What specific matters were submitted to a vote of IRADIMED CORP's security holders on June 20, 2024?
The filing does not specify the exact proposals voted upon by security holders.
What was the outcome of the vote by IRADIMED CORP's security holders?
The filing does not disclose the results or outcome of the shareholder vote.
Is this filing related to a specific corporate action such as a merger or acquisition?
The filing states 'Submission of Matters to a Vote of Security Holders' but does not provide details on the nature of these matters.
When did IRADIMED CORP's fiscal year end?
IRADIMED CORP's fiscal year ends on December 31.
What is IRADIMED CORP's principal executive office address?
IRADIMED CORP's principal executive offices are located at 1025 Willa Springs Dr., Winter Springs, FL 32708.
Filing Stats: 551 words · 2 min read · ~2 pages · Grade level 13 · Accepted 2024-06-20 16:05:25
Key Financial Figures
- $0.0001 — h registered: Common stock, par value $0.0001 IRMD NASDAQ Capital Market Indica
Filing Documents
- irmd-20240620x8k.htm (8-K) — 46KB
- 0001558370-24-009354.txt ( ) — 250KB
- irmd-20240620.xsd (EX-101.SCH) — 3KB
- irmd-20240620_lab.xml (EX-101.LAB) — 1KB
- irmd-20240620_pre.xml (EX-101.PRE) — 10KB
- irmd-20240620x8k_htm.xml (XML) — 5KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. The Annual Meeting of Stockholders of Iradimed Corporation ("Iradimed") was held on Thursday, June 20, 2024. At the meeting, Iradimed's stockholders voted on the following three proposals and cast their votes as described below. 1. Stockholders elected each of Roger Susi, Monty Allen, Anthony Vuoto, Hilda Scharen-Guivel and James Hawkins to Iradimed's Board of Directors, each to hold office until a succeeding annual meeting of stockholders or until such director's successor shall have been duly elected and qualified (or, if earlier, such director's removal or resignation from our Board), as set forth below. Name Votes For Votes Withheld Broker Non-Votes Roger Susi 9,119,299 1,796,092 709,160 Monty Allen 9,709,115 1,206,276 709,160 Anthony Vuoto 10,720,742 194,649 709,160 Hilda Scharen-Guivel 10,741,229 174,162 709,160 James Hawkins 8,771,444 2,143,947 709.160 2. Stockholders ratified the selection of RSM US LLP as Iradimed's independent registered public accounting firm to perform independent audit services for the fiscal year ending December 31, 2024, as set forth below. 11,617,62 Votes For Votes Against Abstentions 11,609,434 13,044 2,073 3. Stockholders approved an advisory resolution on the compensation of Iradimed's named executive officers. Votes For Votes Against Abstentions Broker Non-Votes 10,684,897 197,682 32,812 709,160
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IRADIMED CORPORATION Date: June 20, 2024 By: /s/John Glenn Name: John Glenn Title: Chief Financial Officer